Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengbo Han

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Cell Cycle (Georgetown, Tex.)|December 7, 2018
Circlular RNA BARD1 (Hsa_circ_0001098) overexpression in breast cancer cells with TCDD treatment could promote cell apoptosis via miR-3942/BARD1 axisJianzhu Zhao, Huawei Zou, Chengbo Han, et al.
Human Cell|September 12, 2013
CXCL12 induces lung cancer cell migration by polarized mtDNA redistributionJietao Ma, Jiahe Zheng, Yaoyong Li, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2024
Enhanced T cell immune activity mediated by Drp1 promotes the efficacy of PD-1 inhibitors in treating lung cancerJietao Ma, Jun Song, Xiaofang Yi, et al.
Oncotargets and Therapy|December 11, 2019
Recent Progress in Rare Oncogenic Drivers and Targeted Therapy For Non-Small Cell Lung CancerYijia Guo, Rui Cao, Xiangyan Zhang, et al.
International Immunopharmacology|April 6, 2024
Impact of Drp1-regulated changes in T cell activity on the combined antitumor effects of PARPi and PD-1 inhibitorsJietao Ma, Jun Song, Xiaofang Yi, et al.
Radiation Oncology (London, England)|September 16, 2021
Sintilimab, stereotactic body radiotherapy and granulocyte-macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter, single-arm, phase II trialJianjiao Ni, Yue Zhou, Lin Wu, et al.
Frontiers in Immunology|April 18, 2022
Impact of Drp1-Mediated Mitochondrial Dynamics on T Cell Immune ModulationJun Song, Xiaofang Yi, Ruolin Gao, et al.
Frontiers in Oncology|December 28, 2020
Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A ReviewYijia Guo, Jun Song, Yanru Wang, et al.
Nature Communications|August 22, 2024
Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trialJianjiao Ni, Xiaofei Wang, Lin Wu, et al.
ACS Nano|December 16, 2011
Supramolecular self-assembly of π-conjugated hydrocarbons via 2D cooperative CH/π interactionQing Li, Chengbo Han, Scott R Horton, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cell Cycle (Georgetown, Tex.)|December 7, 2018
Circlular RNA BARD1 (Hsa_circ_0001098) overexpression in breast cancer cells with TCDD treatment could promote cell apoptosis via miR-3942/BARD1 axisJianzhu Zhao, Huawei Zou, Chengbo Han, et al.
Human Cell|September 12, 2013
CXCL12 induces lung cancer cell migration by polarized mtDNA redistributionJietao Ma, Jiahe Zheng, Yaoyong Li, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2024
Enhanced T cell immune activity mediated by Drp1 promotes the efficacy of PD-1 inhibitors in treating lung cancerJietao Ma, Jun Song, Xiaofang Yi, et al.
Oncotargets and Therapy|December 11, 2019
Recent Progress in Rare Oncogenic Drivers and Targeted Therapy For Non-Small Cell Lung CancerYijia Guo, Rui Cao, Xiangyan Zhang, et al.
International Immunopharmacology|April 6, 2024
Impact of Drp1-regulated changes in T cell activity on the combined antitumor effects of PARPi and PD-1 inhibitorsJietao Ma, Jun Song, Xiaofang Yi, et al.
Radiation Oncology (London, England)|September 16, 2021
Sintilimab, stereotactic body radiotherapy and granulocyte-macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter, single-arm, phase II trialJianjiao Ni, Yue Zhou, Lin Wu, et al.
Frontiers in Immunology|April 18, 2022
Impact of Drp1-Mediated Mitochondrial Dynamics on T Cell Immune ModulationJun Song, Xiaofang Yi, Ruolin Gao, et al.
Frontiers in Oncology|December 28, 2020
Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A ReviewYijia Guo, Jun Song, Yanru Wang, et al.
Nature Communications|August 22, 2024
Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trialJianjiao Ni, Xiaofei Wang, Lin Wu, et al.
ACS Nano|December 16, 2011
Supramolecular self-assembly of π-conjugated hydrocarbons via 2D cooperative CH/π interactionQing Li, Chengbo Han, Scott R Horton, et al.
Pageof 3